Intellectual Property
Every innovation that improves lives, advances society, and drives our economy starts with an idea. Strong intellectual property rights—including patents, trademarks, and copyrights—protect and incentivize those ideas. When inventors, researchers, engineers, artists, and entrepreneurs have legal certainty that their work will be protected and rewarded, they can keep the transformative ideas coming. Intellectual property protections also shield consumers from dangerous fake and counterfeit goods, giving people assurances that products—from life-saving medicines to toys—are safe and authentic.
But price controls on medicines could put this progress at risk.
Featured
The U.S. Chamber’s 14th International IP Index evaluates 55 economies across 53 criteria to provide actionable guidance on strengthening intellectual property systems that drive innovation, creativity, and global economic growth.
Learn More
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber’s Global Innovation Policy Center champions innovation and creativity through intellectual property standards so businesses can save lives, solve problems, create jobs, advance growth, and enhance society. Our work to protect strong intellectual property rights begins in Washington, D.C., and extends to countries across the globe.
Latest Content
- Misusing march-in rights for price controls will undermine intellectual property protections, disrupt innovation, and deter private investment.The 2025 Special 301 process gives the Chamber a fresh opportunity to engage and advocate for strong IP protections globally.The Chamber is committed to advocating for patient safety through strong trademark protections and intellectual property (IP) policies.Price controls on medicines may seem like a quick fix, but they ultimately hinder medical innovation and harm patients by reducing the availability of new treatments and cures.Market-restrictive policies like price caps are causing more harm than good for pharmaceutical innovation, and orphan medicines are no exception.The U.S. Chamber is proud to collaborate with Fanatics, MLB, NBA, NFL, and NHL this holiday season to raise awareness of the risks associated with fake league and team-branded products.U.S. Customs and Border Protection and the Chamber share expertise on the dangers of counterfeit goods and how to keep communities safe from illicit trade this holiday seasonShop Smart campaign educates consumers to keep Americans and their families safe from fakesWe talk to Sen. Mazie Hirono (D-HI), winner of this year's excellence in Congressional leadership category, about her plans to improve the patent system, her work to increase protections for artists, and how patent rights incentivize research and innovation
